<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Humphries Falkenberg | Activity</title>
	<link>https://www.catswannabecats.com/members/burstsaw5/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/burstsaw5/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Humphries Falkenberg.</description>
	<lastBuildDate>Tue, 30 Jun 2026 07:59:13 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">e42e57c3b8554e82ba6006a57d843344</guid>
				<title>Humphries Falkenberg posted an update: The prevalence of depressive symptoms was high (29%) and [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23482/</link>
				<pubDate>Sun, 08 Jun 2025 09:17:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>The prevalence of depressive symptoms was high (29%) and correlated significantly to phenylalanine blood concentrations (p = 0.046). However, depressive symptoms were only mild in the majority of patients.</p>
<p> This group of early-treated adult German PKU patients is socially well integrated, reveals a surprisingly high adherence to diet and&hellip;<span class="activity-read-more" id="activity-read-more-23482"><a href="https://www.catswannabecats.com/activity/p/23482/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2f789613c1b55c28b62e90f7fcf4d81d</guid>
				<title>Humphries Falkenberg posted an update: Targeting epidermal growth factor receptor (EGFR) through [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19660/</link>
				<pubDate>Thu, 05 Jun 2025 08:53:58 -0400</pubDate>

									<content:encoded><![CDATA[<p>Targeting epidermal growth factor receptor (EGFR) through tyrosine kinase inhibitors (TKI) is a successful therapeutic strategy in non-small cell lung cancer. However, the response to TKI therapy depends on specific activating and acquired mutations in the tyrosine kinase domain of the EGFR gene. Therefore, confirming the EGFR status of patients&hellip;<span class="activity-read-more" id="activity-read-more-19660"><a href="https://www.catswannabecats.com/activity/p/19660/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3cbe3def7cb7123a9283e5b475dcfb3a</guid>
				<title>Humphries Falkenberg posted an update: Many international and national regulations on radon in [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18358/</link>
				<pubDate>Tue, 03 Jun 2025 13:21:39 -0400</pubDate>

									<content:encoded><![CDATA[<p>Many international and national regulations on radon in workplaces, including the 2013/59/Euratom Council Directive, are based on the annual average of indoor radon concentration, assuming it is representative of the long-term average. However, a single annual radon concentration measurement does not reflect annual variations (i.e. year-to-year&hellip;<span class="activity-read-more" id="activity-read-more-18358"><a href="https://www.catswannabecats.com/activity/p/18358/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e893fa632dbf85c1bc5c162f8475816d</guid>
				<title>Humphries Falkenberg became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/10902/</link>
				<pubDate>Sun, 01 Jun 2025 03:27:42 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>